Literature DB >> 17224209

Prospective immunization of the endangered California condors (Gymnogyps californianus) protects this species from lethal West Nile virus infection.

Gwong-Jen J Chang1, Brent S Davis, Cynthia Stringfield, Christine Lutz.   

Abstract

West Nile virus (WNV) has caused significant morbidity and mortality in humans, mammals, and both native and exotic birds in North America since its emergence in New York City in 1999 and its subsequent spread westward. Prior to the arrival of WNV to the western United States, prospective vaccination was conducted for the entire population of endangered California condors, both in captivity and in the wild. Here we show that this vaccine is safe for condors, stimulates protective immunity in adults, nestlings, and newly hatched chicks. Most importantly, we demonstrate protection of captive birds exposed to naturally circulating WNV during the 2004 transmission season. The prospective vaccination of the entire population of California condors before the arrival of WNV has thus potentially saved this endangered species from subsequent lethal WNV encephalitis, and possible extinction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17224209     DOI: 10.1016/j.vaccine.2006.11.056

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  27 in total

1.  Maternal antibody persistence: a neglected life-history trait with implications from albatross conservation to comparative immunology.

Authors:  R Garnier; R Ramos; V Staszewski; T Militão; E Lobato; J González-Solís; T Boulinier
Journal:  Proc Biol Sci       Date:  2011-12-21       Impact factor: 5.349

2.  Evaluation of Cross-Protection of a Lineage 1 West Nile Virus Inactivated Vaccine against Natural Infections from a Virulent Lineage 2 Strain in Horses, under Field Conditions.

Authors:  Serafeim C Chaintoutis; Nikolaos Diakakis; Maria Papanastassopoulou; Georgios Banos; Chrysostomos I Dovas
Journal:  Clin Vaccine Immunol       Date:  2015-07-15

3.  Efficacy of three vaccines in protecting Western Scrub-Jays (Aphelocoma californica) from experimental infection with West Nile virus: implications for vaccination of Island Scrub-Jays (Aphelocoma insularis).

Authors:  Sarah S Wheeler; Stanley Langevin; Leslie Woods; Brian D Carroll; Winston Vickers; Scott A Morrison; Gwong-Jen J Chang; William K Reisen; Walter M Boyce
Journal:  Vector Borne Zoonotic Dis       Date:  2011-03-25       Impact factor: 2.133

4.  Surveillance for West Nile virus and vaccination of free-ranging island scrub-jays (Aphelocoma insularis) on Santa Cruz Island, California.

Authors:  Walter M Boyce; Winston Vickers; Scott A Morrison; T Scott Sillett; Luke Caldwell; Sarah S Wheeler; Christopher M Barker; Robert Cummings; William K Reisen
Journal:  Vector Borne Zoonotic Dis       Date:  2011-03-25       Impact factor: 2.133

5.  Impact of West Nile Virus on Bird Populations: Limited Lasting Effects, Evidence for Recovery, and Gaps in Our Understanding of Impacts on Ecosystems.

Authors:  A Marm Kilpatrick; Sarah S Wheeler
Journal:  J Med Entomol       Date:  2019-10-28       Impact factor: 2.278

6.  Establishment of an Algorithm Using prM/E- and NS1-Specific IgM Antibody-Capture Enzyme-Linked Immunosorbent Assays in Diagnosis of Japanese Encephalitis Virus and West Nile Virus Infections in Humans.

Authors:  Jedhan U Galula; Gwong-Jen J Chang; Shih-Te Chuang; Day-Yu Chao
Journal:  J Clin Microbiol       Date:  2015-12-09       Impact factor: 5.948

7.  West nile virus: characteristics of an african virus adapting to the third millennium world.

Authors:  Marina Monini; Emiliana Falcone; Luca Busani; Roberto Romi; Franco Maria Ruggeri
Journal:  Open Virol J       Date:  2010-04-22

8.  DNA vaccination of American robins (Turdus migratorius) against West Nile virus.

Authors:  A Marm Kilpatrick; Alan P Dupuis; Gwong-Jen J Chang; Laura D Kramer
Journal:  Vector Borne Zoonotic Dis       Date:  2010-05       Impact factor: 2.133

9.  Enzyme-linked immunosorbent assays using novel Japanese encephalitis virus antigen improve the accuracy of clinical diagnosis of flavivirus infections.

Authors:  Shyan-Song Chiou; Wayne D Crill; Li-Kuang Chen; Gwong-Jen J Chang
Journal:  Clin Vaccine Immunol       Date:  2008-03-12

10.  A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial.

Authors:  Julie E Martin; Theodore C Pierson; Sarah Hubka; Steve Rucker; Ingelise J Gordon; Mary E Enama; Charla A Andrews; Qing Xu; Brent S Davis; Martha Nason; Michael Fay; Richard A Koup; Mario Roederer; Robert T Bailer; Phillip L Gomez; John R Mascola; Gwong-Jen J Chang; Gary J Nabel; Barney S Graham
Journal:  J Infect Dis       Date:  2007-12-15       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.